Mod­er­na cuts back on man­u­fac­tur­ing; Lil­ly eyes Moun­jaro sup­ply boost; GSK’s shin­gles vac­cine ‘un­con­strained’

End­points News dug in­to this week’s earn­ings calls to gath­er bio­phar­ma man­u­fac­tur­ing up­dates. We found that Mod­er­na is cut­ting its man­u­fac­tur­ing ac­tiv­i­ties, while Am­gen pro­vid­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER